Navigation Links
Researchers develop world's first biodegradable joint implant
Date:2/28/2012

Tampere University of Technology (TUT), Finland, has been the first in the world to develop biodegradable joint implant, RegJoint. The implant is used in the treatment of osteoarthritis and rheumatoid arthritis.

RegJoint has recently received CE Mark approval that allows the product to be sold in the European Union. The joint implant, which has been developed since the mid-1990s, is the result of collaboration between the Department of Biomedical Engineering at Tampere University of Technology, Conmed Linvatec Biomaterials, Scaffdex Ltd and a group of orthopaedic surgeons, among others, from Tampere University Hospital. Scaffdex Ltd will bring RegJoint to the market.

New treatment for arthritic patients

Rheumatoid arthritis and osteoarthritis destroy the normally smooth cartilage that lines the ends of bones. As cartilage regenerates poorly, the injuries are difficult to treat. Joint injury reduces mobility and causes pain. The conventional surgical options involve permanent implants or the artificial induction of joint ossification between two bones. RegJoint offers an alternative for conventional surgery and has several advantages over permanent implants. For example, the patient's own bone tissue remains intact during the operation. In addition, the implant makes the reconstruction of the joint more sustainable and cushions the area, relieving pain caused by friction between the bones.

The implant is used to repair injuries in the small joints of the fingers and toes. It is made of biodegradable polylactide copolymer and placed inside the joint capsule that surrounds the joint. The implant stimulates the body to produce connective tissue cells and is gradually replaced by the patient's own soft tissue. RegJoint forms a neojoint between the bone ends and restores normal mobility.

The product has undergone extensive clinical trials in Finland and abroad and patients have reported positive results.


'/>"/>

Contact: Minna Kellomki
minna.kellomaki@tut.fi
358-407-066-312
Tampere University of Technology
Source:Eurekalert

Related biology news :

1. Researchers identify novel pathway responsible for infection of a common STD pathogen
2. Researchers discover how vitamin D inhibits inflammation
3. Purdue researchers reveal role of protein mutation in Parkinsons disease
4. UVic researchers among presenters at global science conference
5. Researchers develop better control for DNA-based computations
6. Researchers warn nanoparticles in food, vitamins could harm human health
7. Worlds top technology researchers coming to Queens for TEI 2012
8. Researchers make living model of brain tumor
9. MDC researchers reveal molecular mechanism underlying severe anomalies of the forebrain
10. Grass to gas: UGA researchers genome map speeds biofuel development
11. Researchers develop new method for creating tissue engineering scaffolds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
(Date:9/30/2019)... ... September 30, 2019 , ... ... mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announced it has received patent ... product formats (patent number AU 2015259373). This new patent adds intellectual property ...
(Date:9/25/2019)... ... , ... Deep Science Ventures (DSV), a new paradigm for applied ... of cancer research. , Deep Science Ventures was founded to create a better method ... from the start, both at the industry and biological level. , Through their ...
Breaking Biology News(10 mins):
(Date:9/30/2019)... (PRWEB) , ... September 30, 2019 , ... ... materials science newsletter from Rigaku Corporation , is now available online on ... to X-ray based materials science, including X-ray diffraction, fluorescence and imaging, and presents ...
(Date:9/24/2019)... (PRWEB) , ... September 24, ... ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... a clinical-stage biopharmaceutical company focused on the development of therapies to treat ...
(Date:9/24/2019)... ... , ... In the past three years, the National Science Foundation (NSF) has ... School of Mines & Technology that expands human understanding of the microbial world. ... slimy and yet strong layer which is commonly known as a biofilm. , The ...
(Date:9/17/2019)... ... 2019 , ... Tucker, a Labrador retriever, was just a puppy when he ... and lame on his right hip and elbow. At one year of age, Tucker ... case the vet had seen.” He was prescribed pain medications, both oral and injectable, ...
Breaking Biology Technology: